Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cymabay Therapeutics Inc. (CBAY)

« Back to company index

CBAY Chatter Timeline

Stock Ticker for CBAY

Most Active Tweeters for CBAY

UserTweets
@StackedBid 4
@BlueBioNow 3
@gcassidy718 2
@wsduckk 2
@dispatchtribune 2

Recent Tweets for CBAY

InsiderForms @InsiderForms
$CBAY Integrated CORE Strategies (US) LLC has filed Form SC 13G/A with SEC. Reporting 4.4% Ownership. https://t.co/t5CkFUZh7T
4:01pm
BlueBioNow @BlueBioNow
$CBAY watching closely ... Over $2.22 this rips 3.06 % change recently https://t.co/5FMbJjXg5G
January 20th 2020, 5:01pm
BlueBioNow @BlueBioNow
$CBAY what a Company 3.06 % change recently https://t.co/5FMbJjXg5G
January 19th 2020, 4:01pm
BlueBioNow @BlueBioNow
$CBAY blockbuster 3.06 % change recently https://t.co/5FMbJjXg5G
January 18th 2020, 5:01pm
TickerSentiment @TickerSentiment
Sentiment for $CBAY out of 23 total scores; 87 % is positive and 13 % is negative. #sentiment https://t.co/tGXGhdvQcA
January 18th 2020, 4:01am
gcassidy718 @gcassidy718
$CBAY Enjoy the weekend everyone! Cheers! ???? 5.36 % change recently https://t.co/FJGm4Lzc67
January 17th 2020, 12:01pm
StackedBid @StackedBid
$CBAY - If this hits $2.19, could get real interesting then its shooting the gap! https://t.co/0doWjCqVkw
January 17th 2020, 10:01am
AlertTrade @AlertTrade
VOLUME RADAR ALERT: $CBAY CymaBay Therapeutics, Inc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room
January 17th 2020, 10:01am
gcassidy718 @gcassidy718
$CBAY The Broad market is turning Green .. Big Green Reversal coming? 5.59 % change recently https://t.co/FJGm4Lzc67
January 16th 2020, 1:01pm
StackedBid @StackedBid
$CBAY - MACD curling up. Looking for a push over $2.04
January 16th 2020, 12:01pm
StackedBid @StackedBid
$CBAY well well well... 1st PT is coming today! https://t.co/0zEgy8ZEDw
January 16th 2020, 10:01am
LargeVoidBot @LargeVoidBot
10:45 Pops: $CBAY +3.6%
January 16th 2020, 10:01am
TickerReport @TickerReport
Head-To-Head Contrast: OncoSec Medical $ONCS & CymaBay Therapeutics $CBAY https://t.co/D6PLEEH91d
January 16th 2020, 3:01am
ZolmaxNews @ZolmaxNews
Reviewing OncoSec Medical $ONCS & CymaBay Therapeutics $CBAY https://t.co/tPxTMkCXsT
January 16th 2020, 3:01am
ThisLincolnian @ThisLincolnian
Analyzing OncoSec Medical $ONCS and CymaBay Therapeutics $CBAY https://t.co/dB2QtEHiiy
January 14th 2020, 1:01am
EnterpriseLeade @EnterpriseLeade
Analyzing OncoSec Medical $ONCS and CymaBay Therapeutics $CBAY https://t.co/KSbghQJU1S
January 14th 2020, 1:01am
wsduckk @wsduckk
All time low, good cash on hand and may be any news about restarting seladelpar trial would be extremely positive $CBAY
January 12th 2020, 11:01am
wsduckk @wsduckk
$CBAY coke back from the dead soon?!
January 12th 2020, 11:01am
Gambiste1 @Gambiste1
RT @StackedBid: $CBAY - Still watching this stock. Cash rich bio name ($3.19 cash/share) with a relatively low float. Entering oversold ter…
January 11th 2020, 6:01pm
StackedBid @StackedBid
$CBAY - Still watching this stock. Cash rich bio name ($3.19 cash/share) with a relatively low float. Entering over… https://t.co/9pgXEEUGVU
January 11th 2020, 5:01pm
dispatchtribune @dispatchtribune
CymaBay Therapeutics Inc $CBAY Given Average Rating of “Hold” by Brokerages https://t.co/XGmi6UTqmo
January 11th 2020, 4:01pm
OlympiaReport @OlympiaReport
CymaBay Therapeutics Inc $CBAY Receives Average Recommendation of “Hold” from Analysts https://t.co/Y7gZFHZO8J
January 11th 2020, 4:01pm
bbnsnews @bbnsnews
Head-To-Head Review: CymaBay Therapeutics $CBAY vs. OncoSec Medical $ONCS https://t.co/8O5Vx0C5nl
January 11th 2020, 7:01am
OlympiaReport @OlympiaReport
CymaBay Therapeutics $CBAY Upgraded to “Buy” by Zacks Investment Research https://t.co/84V69zedHJ
January 11th 2020, 6:01am
dispatchtribune @dispatchtribune
CymaBay Therapeutics $CBAY Upgraded to “Buy” by Zacks Investment Research https://t.co/WodqfG89qo
January 11th 2020, 6:01am
WeekHerald @WeekHerald
CymaBay Therapeutics $CBAY Raised to Buy at Zacks Investment Research https://t.co/RpVD3mZFuG
January 10th 2020, 3:01pm
dakotafinancial @dakotafinancial
CymaBay Therapeutics $CBAY Raised to Buy at Zacks Investment Research https://t.co/0vGNgSPj3d
January 10th 2020, 3:01pm
StockNewsWires @StockNewsWires
$CBAY: CymaBay Therapeutics Enters Oversold Territory: https://t.co/sVQxxNLLnA
January 10th 2020, 8:01am
AmericanBanking @AmericanBanking
Weekly Analysts’ Ratings Updates for CymaBay Therapeutics $CBAY https://t.co/Rs3B43YO92 #stocks
January 9th 2020, 3:01pm
OlympiaReport @OlympiaReport
Weekly Analysts’ Ratings Updates for CymaBay Therapeutics $CBAY https://t.co/vtDYaFTfqw
January 9th 2020, 3:01pm
WeekHerald @WeekHerald
Weekly Analysts’ Ratings Updates for CymaBay Therapeutics $CBAY https://t.co/ahaJXFjn7S
January 9th 2020, 3:01pm
StockPyf @StockPyf
Take a look at this Watchlist: $CBAY $ACHV This is a Filter ScannerAlert scnDollHiVol DateTime: 2020-01-09 10:57 ET
January 9th 2020, 10:01am
ThisLincolnian @ThisLincolnian
CymaBay Therapeutics $CBAY Upgraded to Buy by Zacks Investment Research https://t.co/YmMsCP4A8u
January 9th 2020, 4:01am
newsfilterio @newsfilterio
CymaBay Therapeutics Upgraded to “Buy” by Zacks Investment Research $CBAY https://t.co/U67NA3wMN6
January 8th 2020, 11:01pm
dispatchtribune @dispatchtribune
-$0.39 Earnings Per Share Expected for CymaBay Therapeutics Inc $CBAY This Quarter https://t.co/dT7I44rfsn
January 8th 2020, 2:01pm
OlympiaReport @OlympiaReport
Zacks: Analysts Anticipate CymaBay Therapeutics Inc $CBAY Will Announce Earnings of -$0.39 Per Share https://t.co/NbCEgmB39n
January 8th 2020, 2:01pm
TranscriptDaily @TranscriptDaily
CymaBay Therapeutics $CBAY Upgraded to “Buy” by Zacks Investment Research https://t.co/zQjMWmvjKy
January 8th 2020, 11:01am
stocknewstimes @stocknewstimes
CymaBay Therapeutics $CBAY Upgraded to “Buy” by Zacks Investment Research https://t.co/WfzxQRj6kZ
January 8th 2020, 11:01am
ChartMill @ChartMill
Although the technical rating is bad, $CBAY does present a nice setup opportunity. https://t.co/b04NN4wPXm https://t.co/NCtiPavM8y
January 7th 2020, 10:01pm
bbnsnews @bbnsnews
CymaBay Therapeutics $CBAY Stock Rating Upgraded by ValuEngine https://t.co/tvMrpNU921
January 7th 2020, 5:01pm
AmericanBanking @AmericanBanking
Svb Leerink Reaffirms “Market Perform” Rating for CymaBay Therapeutics $CBAY https://t.co/FL1TadPI0R #stocks
January 7th 2020, 6:01am
StockPyf @StockPyf
Take a look at this Watchlist: $CBAY $ARAY This is a Filter ScannerAlert scnDollHiVol DateTime: 2020-01-06 15:42 ET
January 6th 2020, 3:01pm
StockPyf @StockPyf
Take a look at this Watchlist: $CBAY $AVEO This is a Filter ScannerAlert scnDollHiVol DateTime: 2020-01-06 13:35 ET
January 6th 2020, 1:01pm
ThisLincolnian @ThisLincolnian
-$0.40 EPS Expected for CymaBay Therapeutics Inc $CBAY This Quarter https://t.co/dq0RFLEYdm
January 6th 2020, 9:01am
WatchlistN @WatchlistN
Analysts Anticipate CymaBay Therapeutics Inc $CBAY Will Post Earnings of -$0.40 Per Share https://t.co/RpUEsV8N3f
January 6th 2020, 9:01am
OlympiaReport @OlympiaReport
CymaBay Therapeutics $CBAY Upgraded to Buy at ValuEngine https://t.co/y3D5k880Nb
January 6th 2020, 5:01am
dispatchtribune @dispatchtribune
CymaBay Therapeutics $CBAY Upgraded at ValuEngine https://t.co/u1liev6GsX
January 6th 2020, 5:01am
ThisLincolnian @ThisLincolnian
CymaBay Therapeutics Inc $CBAY Given Consensus Rating of “Hold” by Brokerages https://t.co/b3Co8RdmJp
January 6th 2020, 3:01am
AmericanBanking @AmericanBanking
CymaBay Therapeutics Inc $CBAY Given Consensus Rating of “Hold” by Brokerages https://t.co/T0ZxQ3hhza #stocks
January 6th 2020, 3:01am
Gambiste1 @Gambiste1
RT @smelky_kid: @ZolmaxNews This is how Joel Beatty at Citi operates. He lowers his failed 12 price target on $CBAY from 12 to 2 and issue…
January 5th 2020, 12:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.